Poujol-Robert, Armelle
Rosmorduc, Olivier
Serfaty, Lawrence
Coulet, Florence
Poupon, Raoul
Robert, Annie
[UCL]
OBJECTIVES: During the progression of chronic liver disease towards cirrhosis, morphological studies have shown a close association between parenchymal remodeling and obliterative lesions of intrahepatic small portal and hepatic veins. These lesions are highly suggestive of intrahepatic thrombotic events, which may have a key role in the pathogenesis of hepatic fibrosis. The aim of the study was to investigate thrombotic risk factors in chronic hepatitis C patients with different extent of liver fibrosis. METHODS: The following thrombotic factors were evaluated in 68 hepatitis C patients with prothrombin activity >/= 80% (34 consecutive patients with extensive fibrosis and/or cirrhosis compared with 34 consecutive patients without extensive fibrosis and/or cirrhosis): factor V Leiden, G20210A prothrombin mutation, antithrombin, protein C and S deficiencies, hyperhomocysteinemia, elevated factor VIII level, and lupus anticoagulant. RESULTS: Three thrombotic risk factors were significantly more frequent in patients with extensive fibrosis and/or cirrhosis than in those without extensive fibrosis: protein C deficiency present in 14 patients (41%) as compared with three patients (9%), p= 0.004; elevated factor VIII level present in 19 patients (56%) as compared with six patients (18%), p= 0.002; and hyperhomocysteinemia present in 10 patients (29%) as compared with two patients (6%), p= 0.023. The association of two or three prothrombotic factors was present in 19 patients (56%) with extensive fibrosis and/or cirrhosis as compared with one patient (3%) without extensive fibrosis and/or cirrhosis, p < 0.001. CONCLUSION: Multiple thrombotic risk factors coexist frequently in patients with extensive fibrosis and early stage of cirrhosis. Their association with local inflammation could favor thrombotic events in the liver micro-circulatory bed.
- Rappaport AM, Virchows Arch [Pathol Anat], 402, 107 (1983)
- Goodman ZD, Gastroenterology, 83, 786 (1982)
- Wanless IR, Hepatology, 21, 1238 (1995)
- Alison Malcolm, Golding Matthew, Lalani El-Nasir, Nagy Peter, Thorgeirsson Snorri, Sarraf Catherine, Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells, 10.1016/s0168-8278(97)80051-7
- Rosendaal FR, Venous thrombosis: a multicausal disease, 10.1016/s0140-6736(98)10266-0
- Rosenberg Robert D., Aird William C., Vascular-Bed–Specific Hemostasis and Hypercoagulable States, 10.1056/nejm199905203402007
- Koster T., Vandenbroucke J.P., Rosendaal F.R., Briët E., Rosendaal F.R., Blann A.D., Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis, 10.1016/s0140-6736(95)90166-3
- Rosendaal FR, Semin Hematol, 34, 171 (1997)
- Robert A, Thromb Haemost, 71, 220 (1994)
- Ridker Paul M., Hennekens Charles H., Lindpaintner Klaus, Stampfer Meir J., Eisenberg Paul R., Miletich Joseph P., Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men, 10.1056/nejm199504063321403
- Poort SR, Blood, 88, 3698 (1996)
- The French Metavir Cooperative Study Group, Hepatology, 20, 15 (1994)
- Nygard O, Am J Clin Nutr, 67, 263 (1998)
- Lowe G. D. O., Rumley A., Woodward M., Morrison C. E., Philippou H., Lane D. A., Tunstall-Pedoe H., EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE, 10.1046/j.1365-2141.1997.1222936.x
- Kelly DA, Semin Liver Dis, 7, 182 (1987)
- Tait RC, Thromb Haemost, 73, 87 (1995)
- Manzano M. L., Arocena C., Tomás J. F., Hedner U., Quiroga J. A., Carreño V., Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk : , 10.1097/00001721-200004001-00018
- Dumontier I, Gastroenterol Clin Biol, 16, 120 (1992)
- Kloczko J, Haemostasis, 22, 340 (1992)
- Green AJ, J Lab Clin Med, 83, 189 (1974)
- Maisonneuve P, J Clin Path, 30, 221 (1977)
- Castillo R., Maragall S., Rodés J., Clemente C., Profitós J., Ordinas A., Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease, 10.1016/0049-3848(77)90118-9
- Hankey Graeme J, Eikelboom John W, Homocysteine and vascular disease, 10.1016/s0140-6736(98)11058-9
- Malinow M.R., Nieto F.J., Kruger W.D., Duell P.B., Hess D.L., Gluckman R.A., Block P.C., Holzgang C.R., Anderson P.H., Seltzer D., Upson B., Lin Q.R., The Effects of Folic Acid Supplementation on Plasma Total Homocysteine Are Modulated by Multivitamin Use and Methylenetetrahydrofolate Reductase Genotypes, 10.1161/01.atv.17.6.1157
- Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuve L.P., Rozen R., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, 10.1038/ng0595-111
- Poynard Thierry, Ratziu Vlad, Charlotte Frédéric, Goodman Zachary, McHutchison John, Albrecht Janice, Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, 10.1016/s0168-8278(00)00097-0
- Violi F, Thromb Haemost, 77, 44 (1997)
Bibliographic reference |
Poujol-Robert, Armelle ; Rosmorduc, Olivier ; Serfaty, Lawrence ; Coulet, Florence ; Poupon, Raoul ; et. al. Genetic and acquired thrombotic factors in chronic hepatitis C.. In: The American journal of gastroenterology, Vol. 99, no. 3, p. 527-31 (2004) |
Permanent URL |
http://hdl.handle.net/2078.1/25837 |